Methylation of PITX2, HOXD3, RASSF1 and TDRD1 predicts biochemical recurrence in high-risk prostate cancer.

Litovkin, Kirill

Methylation of PITX2, HOXD3, RASSF1 and TDRD1 predicts biochemical recurrence in high-risk prostate cancer. [electronic resource] - Journal of cancer research and clinical oncology Nov 2014 - 1849-61 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

1432-1335

10.1007/s00432-014-1738-8 doi


Aged
Aged, 80 and over
Carrier Proteins--genetics
Cell Cycle Proteins
Cell Line, Tumor
DNA Methylation
Homeodomain Proteins--genetics
Humans
Kallikreins--blood
Male
Middle Aged
Neoplasm Recurrence, Local--blood
Promoter Regions, Genetic
Proportional Hazards Models
Prostate-Specific Antigen--blood
Prostatic Hyperplasia--genetics
Prostatic Neoplasms--blood
Transcription Factors--genetics
Tumor Suppressor Proteins--genetics
Homeobox Protein PITX2